Melphalan
DrugBank ID: DB01042
Summary
| Metric | Value |
|---|---|
| Total Predictions | 53 |
| KG+DL (Dual Validated) | 15 |
| DL Only | 35 |
| KG Only | 3 |
Predictions
| Indication | Score | Source |
|---|---|---|
| hereditary breast ovarian cancer syndrome | 0.9994 | DL |
| malignant dysgerminomatous germ cell tumor of ovary | 0.9987 | KG+DL |
| ovarian clear cell adenocarcinoma | 0.9984 | KG+DL |
| primary non-gestational choriocarcinoma of ovary | 0.9984 | KG+DL |
| maligant granulosa cell tumor of ovary | 0.9981 | KG+DL |
| hereditary site-specific ovarian cancer syndrome | 0.9978 | DL |
| borderline epithelial tumor of ovary | 0.9977 | KG+DL |
| gonadal germ cell tumor | 0.9977 | DL |
| ovarian primitive germ cell tumor | 0.9975 | DL |
| choriocarcinoma of ovary | 0.9974 | DL |
| female breast carcinoma | 0.9967 | DL |
| ovarian mucinous adenocarcinoma | 0.9961 | KG+DL |
| malignant sex cord stromal tumor of ovary | 0.9958 | KG+DL |
| malignant non-epithelial tumor of ovary | 0.9955 | DL |
| malignant germ cell tumor of ovary | 0.9949 | KG+DL |
| familial ovarian cancer | 0.9944 | DL |
| ovarian endometrioid adenocarcinoma | 0.9944 | KG+DL |
| ovarian small cell carcinoma | 0.9941 | KG+DL |
| rectum mucinous adenocarcinoma | 0.9938 | DL |
| theca steroid-producing cell malignant tumor of ovary, not further specified | 0.9938 | KG+DL |
| colon mucinous adenocarcinoma | 0.9936 | DL |
| malignant non-dysgerminomatous germ cell tumor of ovary | 0.9936 | KG+DL |
| ovarian carcinosarcoma | 0.9935 | KG+DL |
| gallbladder mucinous adenocarcinoma | 0.9929 | DL |
| cervical mucinous adenocarcinoma | 0.9927 | DL |
| endometrial mucinous adenocarcinoma | 0.9926 | DL |
| extrahepatic bile duct mucinous adenocarcinoma | 0.9922 | DL |
| ovarian neoplasm | 0.9921 | DL |
| ovarian adenocarcinoma | 0.9920 | KG+DL |
| lung colloid adenocarcinoma | 0.9920 | DL |
| colorectal adenocarcinoma | 0.9920 | DL |
| ovarian cystadenocarcinoma | 0.9919 | DL |
| rete ovarii adenocarcinoma | 0.9918 | DL |
| yolk sac tumor | 0.9918 | KG+DL |
| endometrial mixed adenocarcinoma | 0.9916 | DL |
| villoglandular endometrial endometrioid adenocarcinoma | 0.9916 | DL |
| Krukenberg carcinoma | 0.9913 | DL |
| fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement | 0.9909 | DL |
| ovarian Sertoli-Leydig cell tumor | 0.9907 | DL |
| mucin-rich endometrial endometrioid adenocarcinoma | 0.9905 | DL |
| secretory uterine corpus endometrioid adenocarcinoma | 0.9905 | DL |
| gonadoblastoma | 0.9904 | DL |
| ovarian gynandroblastoma | 0.9901 | DL |
| ovarian cystic teratoma | 0.9899 | DL |
| breast-ovarian cancer, familial, susceptibility to | 0.9899 | DL |
| malignant germ cell tumor of cervix uteri | 0.9898 | DL |
| stage I endometrioid carcinoma | 0.9897 | DL |
| stage II endometrioid carcinoma | 0.9897 | DL |
| urethral valve | 0.9897 | DL |
| ovarian sex cord-stromal tumor | 0.9896 | DL |
Showing top 50 of 53 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.